Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep 16;13(9):5920-46.
doi: 10.3390/md13095920.

Therapies from Fucoidan: An Update

Affiliations
Review

Therapies from Fucoidan: An Update

Janet Helen Fitton et al. Mar Drugs. .

Abstract

Fucoidans are a class of sulfated fucose-rich polysaccharides found in brown marine algae and echinoderms. Fucoidans have an attractive array of bioactivities and potential applications including immune modulation, cancer inhibition, and pathogen inhibition. Research into fucoidan has continued to gain pace over the last few years and point towards potential therapeutic or adjunct roles. The source, extraction, characterization and detection of fucoidan is discussed.

Keywords: anti-bacterial; anti-cancer; anti-inflammatory; anti-viral; immune modulation; sulfated carbohydrate.

PubMed Disclaimer

References

    1. Berteau O., Mulloy B. Sulfated fucans, fresh perspectives: Structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology. 2003;13:29–40. doi: 10.1093/glycob/cwg058. - DOI - PubMed
    1. Kannan R.R., Arumugam R., Anantharaman P. Pharmaceutical potential of a fucoidan-like sulphated polysaccharide isolated from Halodule pinifolia. Int. J. Biol. Macromol. 2013;62:30–34. doi: 10.1016/j.ijbiomac.2013.08.005. - DOI - PubMed
    1. Fitton J. Therapies from fucoidan; multifunctional marine polymers. Mar. Drugs. 2011;9:1731–1760. doi: 10.3390/md9101731. - DOI - PMC - PubMed
    1. Kwak J.Y. Fucoidan as a marine anticancer agent in preclinical development. Mar. Drugs. 2014;12:851–870. doi: 10.3390/md12020851. - DOI - PMC - PubMed
    1. Pomin V.H. Fucanomics and galactanomics: Current status in drug discovery, mechanisms of action and role of the well-defined structures. Biochim. Biophys. Acta. 2012;1820:1971–1979. doi: 10.1016/j.bbagen.2012.08.022. - DOI - PubMed

MeSH terms

LinkOut - more resources